DK1254159T3 - Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider - Google Patents

Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider

Info

Publication number
DK1254159T3
DK1254159T3 DK01911497T DK01911497T DK1254159T3 DK 1254159 T3 DK1254159 T3 DK 1254159T3 DK 01911497 T DK01911497 T DK 01911497T DK 01911497 T DK01911497 T DK 01911497T DK 1254159 T3 DK1254159 T3 DK 1254159T3
Authority
DK
Denmark
Prior art keywords
cyclohexylglycylpyridylalanine
acetylamidiniophenylalanyl
amides
preparation
cyclohexylglycylpyridylalanine amides
Prior art date
Application number
DK01911497T
Other languages
English (en)
Inventor
Dr Gerhard Breipohl
Wolfgang Holla
Heiner Jendralla
Gerhard Beck
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1254159T3 publication Critical patent/DK1254159T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
DK01911497T 2000-01-28 2001-01-18 Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider DK1254159T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10003586 2000-01-28

Publications (1)

Publication Number Publication Date
DK1254159T3 true DK1254159T3 (da) 2006-09-11

Family

ID=7628946

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01911497T DK1254159T3 (da) 2000-01-28 2001-01-18 Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider

Country Status (30)

Country Link
US (2) US20010031858A1 (da)
EP (1) EP1254159B9 (da)
JP (1) JP4778181B2 (da)
KR (1) KR100758141B1 (da)
CN (1) CN1176104C (da)
AR (1) AR027246A1 (da)
AT (1) ATE325810T1 (da)
AU (1) AU779722B2 (da)
BR (1) BR0107804A (da)
CA (1) CA2398497C (da)
CZ (1) CZ20022583A3 (da)
DE (1) DE60119491T2 (da)
DK (1) DK1254159T3 (da)
EE (1) EE200200410A (da)
ES (1) ES2262632T3 (da)
HK (1) HK1051866A1 (da)
HR (1) HRP20020631A2 (da)
HU (1) HUP0301986A2 (da)
IL (2) IL150897A0 (da)
MX (1) MXPA02006762A (da)
NO (1) NO20023577L (da)
NZ (1) NZ520427A (da)
PL (1) PL356801A1 (da)
PT (1) PT1254159E (da)
RU (1) RU2250212C2 (da)
SK (1) SK10842002A3 (da)
TW (1) TWI236481B (da)
WO (1) WO2001055175A2 (da)
YU (1) YU51202A (da)
ZA (1) ZA200205990B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695999A5 (de) 2002-02-28 2006-11-15 Wilex Ag Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten.
JP2009518345A (ja) * 2005-12-07 2009-05-07 テフニーシェ ウニヴェルジテート ミュンヘン 因子viiiおよび因子viii様タンパク質に対する小型ペプチドおよびペプチド模倣物の親和性リガンド
CN101774942B (zh) * 2010-01-27 2012-08-22 宁波武盛化学有限公司 制备n-乙酰基-dl-环己基甘氨酸的方法
ES2686298T3 (es) * 2010-04-20 2018-10-17 Chiral Quest, Inc. Procedimiento enantioselectivo para alaninas beta sustituidas con cicloalquenilo
EP2646150A4 (en) * 2010-11-29 2014-10-08 Takasago Perfumery Co Ltd CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR PRODUCING AN OPTICALLY ACTIVE CARBONYL COMPOUND THEREWITH
CN115068469B (zh) * 2022-07-08 2024-02-27 深圳市小分子新药创新中心有限公司 Tigit抑制剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US5849510A (en) 1994-04-26 1998-12-15 Selectide Corporation Factor Xa inhibitors
CN1181091C (zh) * 1994-04-26 2004-12-22 西莱克泰德公司 因子Xa抑制剂
EP0868526B1 (en) * 1995-12-20 2002-08-14 Aventis Pharmaceuticals Inc. PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-BETA-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH2
DE19856443A1 (de) 1998-12-08 2000-06-21 Centeon Pharma Gmbh Stabilisiertes Antithrombin III-Präparat

Also Published As

Publication number Publication date
NO20023577D0 (no) 2002-07-26
MXPA02006762A (es) 2002-10-23
EP1254159B9 (en) 2006-06-28
PT1254159E (pt) 2006-07-31
NZ520427A (en) 2004-02-27
WO2001055175A2 (en) 2001-08-02
CN1396928A (zh) 2003-02-12
DE60119491T2 (de) 2006-11-16
DE60119491D1 (de) 2006-06-14
AU779722B2 (en) 2005-02-10
HUP0301986A2 (hu) 2003-09-29
HK1051866A1 (en) 2003-08-22
ZA200205990B (en) 2003-04-30
EP1254159A2 (en) 2002-11-06
YU51202A (sh) 2005-11-28
EP1254159B1 (en) 2006-05-10
AU4051601A (en) 2001-08-07
KR100758141B1 (ko) 2007-09-13
CA2398497C (en) 2011-04-26
KR20030019306A (ko) 2003-03-06
JP4778181B2 (ja) 2011-09-21
AR027246A1 (es) 2003-03-19
WO2001055175A3 (en) 2002-02-21
RU2250212C2 (ru) 2005-04-20
US20040225109A1 (en) 2004-11-11
CZ20022583A3 (cs) 2002-10-16
HRP20020631A2 (en) 2004-12-31
ES2262632T3 (es) 2006-12-01
CN1176104C (zh) 2004-11-17
IL150897A (en) 2008-08-07
TWI236481B (en) 2005-07-21
EE200200410A (et) 2003-12-15
JP2003523364A (ja) 2003-08-05
US20010031858A1 (en) 2001-10-18
PL356801A1 (en) 2004-07-12
US7084250B2 (en) 2006-08-01
ATE325810T1 (de) 2006-06-15
CA2398497A1 (en) 2001-08-02
RU2002123046A (ru) 2004-01-10
NO20023577L (no) 2002-08-28
BR0107804A (pt) 2002-10-22
IL150897A0 (en) 2003-02-12
SK10842002A3 (sk) 2003-04-01

Similar Documents

Publication Publication Date Title
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1044969T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser
DK1293507T3 (da) Fremgangsmåde til fremstilling af krystaller
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1253153T3 (da) Fremgangsmåde til fremstilling af 4"-substituerede-9-deoxo-9a-aza-9a-homoerythromycin-A-derivater
DK1181272T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1309582T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1181713T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1263717T3 (da) Fremgangsmåde til fremstilling af methionin
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1254159T3 (da) Fremgangsmåde til fremstilling af acetylamidiniophenylalanylcyclohexylglycylpyridylalaninamider
DE60031450D1 (de) Polymorph v von torasemid
DK1286940T3 (da) Fremgangsmåde til fluormethylering af alkoholer
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner